FindTrial
Sign In

Polypoidal Choroidal Vasculopathy

Sensitivity and specificity of Spectral Domain Optical Coherence Tomography in diagnosing Polypoidal Choroidal Vasculopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/05/014061
Enrollment
63
Registered
2018-05-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL

Sponsors

Giridhar Eye Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with PCV based on typical clinical and angiographic findings.

Exclusion criteria

Exclusion criteria: Those patients who are not diagnosed for PCV.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of SD-OCT in diagnosing Idiopathic Polypoidal Choroidal Vasculopathy.Timepoint: 12 Months—

Secondary

MeasureTime frame
To do a qualitative analysis of the morphology of PED in Idiopathic Polypoidal Choroidal Vasculopathy.Timepoint: 12 Months—

Countries

India

Contacts

Public ContactDr A Giridhar

Giridhar Eye Institute

nithinkeshav@gmail.com04844170000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026